Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common ...

Antibodies that bind to two targets are an established way of treating the blood cancer multiple myeloma. Aiming to top those medicines, AbbVie has secured rights to an early-clinical drug that works ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

Gregg is professor of neurobiology and human genetics at the University of Utah. In 2018, I waited until after Christmas to inform my 10- and 12-year-old children that I had metastatic male breast ...

Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors learning to shrug off chemotherapy that once held them in check. A new wave of ...

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

File photo: — Patient Receives Chemotherapy. Source - National Cancer Institute/ Rhoda Baer (Photographer). Public Domain — CC0 1.0 Universal File photo: — Patient Receives Chemotherapy. Source - ...

Ovarian cancer treatment faces challenges with high relapse and drug resistance rates, despite initial chemotherapy effectiveness. Cytokines like IL-6 and IL-11 are associated with complex tumor ...

Johnson & Johnson currently boasts one of the largest lineups of multiple myeloma products. Since its first FDA approval of a drug for this type of blood cancer a decade ago, the pharmaceutical giant ...